Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Roles for BLyS family members in meeting the distinct homeostatic demands of innate and adaptive B cells.

Sindhava VJ, Scholz JL, Cancro MP.

Front Immunol. 2013 Feb 25;4:37. doi: 10.3389/fimmu.2013.00037. eCollection 2013.

PMID:
23443938
[PubMed]
Free PMC Article
2.

The BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation.

Cancro MP.

Immunol Rev. 2004 Dec;202:237-49. Review.

PMID:
15546397
[PubMed - indexed for MEDLINE]
3.

BLyS receptor signatures resolve homeostatically independent compartments among naïve and antigen-experienced B cells.

Treml LS, Crowley JE, Cancro MP.

Semin Immunol. 2006 Oct;18(5):297-304. Epub 2006 Aug 17. Review.

PMID:
16919470
[PubMed - indexed for MEDLINE]
4.

TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells.

Treml LS, Carlesso G, Hoek KL, Stadanlick JE, Kambayashi T, Bram RJ, Cancro MP, Khan WN.

J Immunol. 2007 Jun 15;178(12):7531-9.

PMID:
17548587
[PubMed - indexed for MEDLINE]
Free Article
5.

Homeostatic niche specification among naïve and activated B cells: a growing role for the BLyS family of receptors and ligands.

Crowley JE, Treml LS, Stadanlick JE, Carpenter E, Cancro MP.

Semin Immunol. 2005 Jun;17(3):193-9. Review.

PMID:
15826824
[PubMed - indexed for MEDLINE]
6.

B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals.

Smith SH, Haas KM, Poe JC, Yanaba K, Ward CD, Migone TS, Tedder TF.

Int Immunol. 2010 Aug;22(8):681-91. doi: 10.1093/intimm/dxq055. Epub 2010 May 31.

PMID:
20513733
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B-cell maturation antigen-immunoglobulin.

Dillon SR, Harder B, Lewis KB, Moore MD, Liu H, Bukowski TR, Hamacher NB, Lantry MM, Maurer M, Krejsa CM, Ellsworth JL, Pederson S, Elkon KB, Wener MH, Dall'Era M, Gross JA.

Arthritis Res Ther. 2010;12(2):R48. doi: 10.1186/ar2959. Epub 2010 Mar 19.

PMID:
20302641
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

APRIL mediates peritoneal B-1 cell homeostasis.

Sindhava VJ, Scholz JL, Stohl W, Cancro MP.

Immunol Lett. 2014 Aug;160(2):120-7. doi: 10.1016/j.imlet.2014.01.018. Epub 2014 Feb 7.

PMID:
24512739
[PubMed - in process]
9.

TACI-Ig induces immune balance of Th cells in MLN via BLyS/APRIL-receptors signaling in rats with adjuvant-induced arthritis.

Qin Q, Chang Y, Wang D, Wu Y, Zhang LL, Wei W.

Int Immunopharmacol. 2011 Dec;11(12):2167-75. doi: 10.1016/j.intimp.2011.09.014. Epub 2011 Oct 11.

PMID:
21996540
[PubMed - indexed for MEDLINE]
10.

BLyS and APRIL in rheumatoid arthritis.

Seyler TM, Park YW, Takemura S, Bram RJ, Kurtin PJ, Goronzy JJ, Weyand CM.

J Clin Invest. 2005 Nov;115(11):3083-92. Epub 2005 Oct 20.

PMID:
16239971
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors.

Jelinek DF, Darce JR.

Curr Dir Autoimmun. 2005;8:266-88. Review.

PMID:
15564725
[PubMed - indexed for MEDLINE]
12.

Peripheral B cell selection and homeostasis.

Cancro MP, Smith SH.

Immunol Res. 2003;27(2-3):141-8. Review.

PMID:
12857963
[PubMed - indexed for MEDLINE]
13.

Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.

Morel J, Roubille C, Planelles L, Rocha C, Fernandez L, Lukas C, Hahne M, Combe B.

Ann Rheum Dis. 2009 Jun;68(6):997-1002. doi: 10.1136/ard.2008.090928. Epub 2008 Aug 2.

PMID:
18676986
[PubMed - indexed for MEDLINE]
14.

Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response.

Do RK, Hatada E, Lee H, Tourigny MR, Hilbert D, Chen-Kiang S.

J Exp Med. 2000 Oct 2;192(7):953-64.

PMID:
11015437
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

B lymphocyte stimulator (BLyS): a therapeutic trichotomy for the treatment of B lymphocyte diseases.

Nardelli B, Moore PA, Li Y, Hilbert DM.

Leuk Lymphoma. 2002 Jul;43(7):1367-73. Review.

PMID:
12389615
[PubMed - indexed for MEDLINE]
16.

The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity.

Cancro MP.

Ann Rheum Dis. 2006 Nov;65 Suppl 3:iii34-6. Review.

PMID:
17038469
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival.

Novak AJ, Bram RJ, Kay NE, Jelinek DF.

Blood. 2002 Oct 15;100(8):2973-9.

PMID:
12351410
[PubMed - indexed for MEDLINE]
Free Article
18.

Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas.

Fu L, Lin-Lee YC, Pham LV, Tamayo A, Yoshimura L, Ford RJ.

Blood. 2006 Jun 1;107(11):4540-8. Epub 2006 Feb 23.

PMID:
16497967
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Synthesis and release of B-lymphocyte stimulator from myeloid cells.

Nardelli B, Belvedere O, Roschke V, Moore PA, Olsen HS, Migone TS, Sosnovtseva S, Carrell JA, Feng P, Giri JG, Hilbert DM.

Blood. 2001 Jan 1;97(1):198-204.

PMID:
11133761
[PubMed - indexed for MEDLINE]
Free Article
20.

B cells and aging: balancing the homeostatic equation.

Miller JP, Cancro MP.

Exp Gerontol. 2007 May;42(5):396-9. Epub 2007 Feb 4. Review.

PMID:
17344004
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk